EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS023-05305 
Organism
Homo sapiens 
Tissue/cell
CD8+ 
Coordinate
chr12:4273280-4274910 
TF binding sites/motifs
Number: 4             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
NKX2-3MA0672.1chr12:4274721-4274731TTCAAGTGGT-6.02
ZNF263MA0528.1chr12:4274548-4274569TTCTTCCCCATTTCCTCCTCA-6.13
ZNF263MA0528.1chr12:4274135-4274156GGAGGAGCCGGGAGGGAGAGG+6.1
ZNF263MA0528.1chr12:4273779-4273800GCCTTCTCCTGCTCCTCCTCT-6.45
Number of super-enhancer constituents: 4             
IDCoordinateTissue/cell
SE_10702chr12:4273459-4274966CD19_Primary
SE_11778chr12:4273012-4275197CD20
SE_58886chr12:4216067-4279606Ly3
SE_61003chr12:4215547-4279853HBL1
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr1242741134274463
chr1242734004274000
Number: 1             
IDChromosomeStartEnd
GH12I004164chr1242732724275018
Enhancer Sequence
CAGTATATTT TTAAATGTCA ATAAAATGTC AATATGGCAA AAGTCACACC ATTTGTAAGT 60
ATTTAAACTT ATGATAAAGC ATTTTAGATG CTTGACGGGT CATTTTCAAA ATTATGTTCC 120
AAATTGTCTT AGGGGCATGC GAAGGCCACC CTTCTGGTCT CCGCAGCTCC GCTCCCCAGG 180
ACAGCGGCTT CCTAGGGCTG TCTCTGTGCA TCTTCAAGGA GGGCGACTTC TTGGTTCAAG 240
TCCCAAGCTC ACCTCCTTGC TTCCATTCTC AGGTTGGTCC CCAGGGCGTG AGACACACCA 300
ACGCTCCCAT TCCCTCTAGT TTCTCTCTTT CCCCCACTTT CTCACTCGTT TCAAGAGAAC 360
GTTCCTATCC AGCGAATTTG TCATCATTTT CACTGCCTGG GTAACAACCA TCGCAGCTGC 420
CTTTTTTTTT TTTTTTTTTT TTTCTTGCAG GGAATGGGCC TGGAGCCGTG AGCCGTCCCC 480
TTCGCTAACC CCCAACCCCG CCTTCTCCTG CTCCTCCTCT CTTCACTCTT CCTGCCTCTC 540
GGCTCCGGGG TCTCCTCGCT TCCCCGCAGT CCCCGCCCCC CAGTTCCCAA AGCGGCACCC 600
GGGCCTCGCC TCCTTCCAGC GGAGCCGCGC GCCCTGCGTC CTGGCCTCCC CGCCCCGAGT 660
CCCCTTCCCT GGAGCCTGGG GGACCGACAG TCGCGGGCCA CGCACGCGGT CCCAGCCTCG 720
CCGTCCGCCC CGGGGAGAGC TGGAAGGTGG GCCCGGATCT CCCACATCAC TATGAGCTCA 780
TTCCAGCCCC GGCCAAGCAA AGCCTGGCCC TACTCGCTCC ACATGCATTT CAGTCTCCTC 840
TCGCCTTTCA TGCGCGGAGG AGCCGGGAGG GAGAGGATGT GACCTCATCT GCGCGGCATC 900
TGAGCCCAGG GGTGCCCCAG CTCTTCCACC CAGGCCGCTC CCCGAGCCCA GCTCCCCGCG 960
CCCCTCTCTC TATCCAGGAG AGACGCATTG GACAGCCAGG AGGGCTCGAC GTGGAAGGAA 1020
AGGAAGCTGC AATTCTGGGA CAGGGGCAGA CGGGAGAGGA AGTGAACGTG GCTAAACGCT 1080
CACTTTATGT AAAACGTCCC CCAGACTAGA ATCTCGTCCA CAGAGCTGCA CACATACACT 1140
CGCACGGGCC CGGCTTGTAC TCAGGCAGGC ACACTCGCCC CCCGCCGTCC CCACCGCATC 1200
CCCCATACCC GTCCTAACTC ACTCCAGCCC CAATACAACC AAAAGGCATG AATTCAGGCG 1260
AAGGCGTTTT CTTCCCCATT TCCTCCTCAT GGCAGCAACG GAAACCTGAA TCTCAGAGCT 1320
GCCATGGGAC CAGGGGGCCA ACAGACCAGA GGCACCATCC TCAGAGCCCC CGGTCTGCCT 1380
GGGACTGGGA GCATGGCTGT GGCGCCCAAT GAGAACATAG TGTCCATAGT GACCATGATT 1440
CTTCAAGTGG TGTCTGAATT TCCCACATTA GCTAAATTCC TTTGGGAGCT TCAGGGTTTC 1500
CAGTCTTCCA GGGTTTTTGG CTTAAATGCA AGTACCTCTT GGAAGAATGG CACATGCCCC 1560
CATACCCTCA GGGTAATGGG ACAAGGAGAA GATGGAGTAG GGGGTGAGGC TCAGAAAGGC 1620
AAGGGAAAGT 1630